• OPEN AN ACCOUNT
Indian Indices
Sensex
84,679.86 -533.50
( -0.63%)
Global Indices
Nasdaq
48,441.87 -37.19
(-0.08%)
Dow Jones
6,837.99 -10.42
(-0.15%)
Hang Seng
49,445.34 -722.77
(-1.44%)
Nikkei 225
9,668.67 -82.64
(-0.85%)
Forex
USD-INR
90.53 0.34
(0.38%)
EUR-INR
106.28 0.58
(0.55%)
GBP-INR
121.02 0.27
(0.22%)
JPY-INR
0.58 0.00
(0.23%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
174.4719509
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
44.34
14255.53
EPS(TTM)
Face Value()
Div & Yield %
30.73
1
0.64
 

CarTrade Tech climbs on acquisition talks
Nov 11,2025
The company said it is exploring a potential consolidation of their automotive classifieds businesses as part of its ongoing growth strategy. CarTrade added that the talks are limited to the auto classifieds segment and exclude Girnar's financing, insurance, and other non-automotive operations.

CarTrade clarified that no binding or definitive agreement has been signed yet. 'If any binding document is executed, the company will make the necessary disclosure in accordance with SEBI’s Listing Obligations and Disclosure Requirements,' it said in a statement.

CarTrade Tech is India’s largest digital marketplace ecosystem, operating multiple platforms including CarWale, BikeWale, CarTrade, OLX India, Shriram Automall, CarTrade Exchange, and Adroit Auto. These platforms empower millions of users including consumers, dealers, OEMs, and enterprises to buy and sell vehicles, real estate, electronics, mobile phones, furniture, and more with ease and efficiency.

On a consolidated basis, CarTrade reported revenue of Rs 222.14 crore in Q2FY26, resulting in YoY growth of 29%. Profit after tax for the quarter stood at Rs 64.08 crore, resulting in YoY growth of 109%.